Bharat Biotech sees no impact of Ukraine conflict on vaccine supply chains

Unlike several Western companies, no Indian company has publicly withdrawn from the region.

Indian vaccine maker Bharat Biotech said on Friday the Russia-Ukraine conflict had not impacted the company's supply chains so far.

Unlike several Western companies including McDonald's, Microsoft, Coca-Cola and Starbucks that have stopped sales or operations in Russia, no Indian company has publicly withdrawn from the region.

A few Indian pharmaceutical companies have a presence in Russia, exporting and selling medicines in the country. Sales to Russia between April and December last year reached $386 million, or 15% of the total exports to the country.

Dr Reddy's Laboratories said on Wednesday it was focused on business continuity in and around